KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

AbbVie (ABBV) Assets Average (2016 - 2025)

Historic Assets Average for AbbVie (ABBV) over the last 13 years, with Q3 2025 value amounting to $135.5 billion.

  • AbbVie's Assets Average fell 500.39% to $135.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $135.5 billion, marking a year-over-year decrease of 500.39%. This contributed to the annual value of $134.9 billion for FY2024, which is 133.23% down from last year.
  • Per AbbVie's latest filing, its Assets Average stood at $135.5 billion for Q3 2025, which was down 500.39% from $136.7 billion recorded in Q2 2025.
  • In the past 5 years, AbbVie's Assets Average registered a high of $150.5 billion during Q1 2021, and its lowest value of $135.0 billion during Q2 2023.
  • In the last 5 years, AbbVie's Assets Average had a median value of $141.8 billion in 2024 and averaged $141.4 billion.
  • Per our database at Business Quant, AbbVie's Assets Average skyrocketed by 6696.76% in 2021 and then tumbled by 600.53% in 2025.
  • Over the past 5 years, AbbVie's Assets Average (Quarter) stood at $147.7 billion in 2021, then fell by 5.17% to $140.1 billion in 2022, then fell by 3.28% to $135.5 billion in 2023, then grew by 2.82% to $139.3 billion in 2024, then dropped by 2.69% to $135.5 billion in 2025.
  • Its Assets Average stands at $135.5 billion for Q3 2025, versus $136.7 billion for Q2 2025 and $135.7 billion for Q1 2025.